Gliogenesis in Neurodegeneration

Migration, Crosslink

📖

Gliogenesis in Neurodegeneration

active

wiki page Created: 2026-04-02T07:20:01 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-mechanisms-gliogenesis-neurodegener

📖 Wiki Page

mechanism2034 wordssynced 2026-04-02

Gliogenesis in Neurodegeneration

Overview

Gliogenesis in Neurodegeneration describes a critical molecular and cellular mechanism implicated in neurodegenerative disease. This page provides a comprehensive overview of glial cell development, dysfunction, and their contributions to conditions such as Alzheimer's disease (AD), Parkinson's disease (PD), Amyotrophic Lateral Sclerosis (ALS), and Multiple Sclerosis (MS). [@colonna2016]

Gliogenesis refers to the formation and development of glial cells — [astrocytes](/cell-types/astrocytes), oligodendrocytes, and [microglia](/cell-types/microglia-neuroinflammation) — from neural progenitor cells during development and in adulthood. While [neurons](/entities/neurons) dominate discussions of neurodegeneration, glial cells are equally critical to neuronal health, and their dysfunction contributes significantly to disease progression [1]. [@gomeznicola2015]

Types of Gliogenesis

Astrocytogenesis

The generation of astrocytes from radial glial cells and astrocyte progenitors represents a fundamental process in central nervous system development. Key processes include: [@cheng2015]

...

Gliogenesis in Neurodegeneration

Overview

Gliogenesis in Neurodegeneration describes a critical molecular and cellular mechanism implicated in neurodegenerative disease. This page provides a comprehensive overview of glial cell development, dysfunction, and their contributions to conditions such as Alzheimer's disease (AD), Parkinson's disease (PD), Amyotrophic Lateral Sclerosis (ALS), and Multiple Sclerosis (MS). [@colonna2016]

Gliogenesis refers to the formation and development of glial cells — [astrocytes](/cell-types/astrocytes), oligodendrocytes, and [microglia](/cell-types/microglia-neuroinflammation) — from neural progenitor cells during development and in adulthood. While [neurons](/entities/neurons) dominate discussions of neurodegeneration, glial cells are equally critical to neuronal health, and their dysfunction contributes significantly to disease progression [1]. [@gomeznicola2015]

Types of Gliogenesis

Astrocytogenesis

The generation of astrocytes from radial glial cells and astrocyte progenitors represents a fundamental process in central nervous system development. Key processes include: [@cheng2015]

[GFAP](/entities/gfap)-positive progenitors — Radial glial cells give rise to astrocyte progenitors expressing glial fibrillary acidic protein (GFAP) [2]
S100β expression — Marker of mature astrocyte differentiation, indicating successful astrocytic commitment [3]
Astrocyte maturation factors — Include CNTF (Ciliary Neurotrophic Factor), LIF (Leukemia Inhibitory Factor), and BMP (Bone Morphogenetic Protein) signaling [4]

In the adult brain, astrocytes can proliferate in response to injury through a process called reactive astrocytosis, characterized by upregulation of GFAP and cellular hypertrophy [5]. [@miron2013]

Oligodendrogenesis

The production of oligodendrocytes from oligodendrocyte precursor cells (OPCs), also known as NG2-positive cells, is essential for myelination: [@morganti2016]

PDGFRA-positive OPCs — Platelet-Derived Growth Factor Receptor Alpha positive progenitors proliferate and differentiate in response to signals [6]
NG2 proteoglycan — Surface marker distinguishing OPCs from other glial lineages [7]
MBP and PLP — Myelin Basic Protein and Proteolipid Protein are hallmark markers of mature, myelinating oligodendrocytes [8]

OPC recruitment and differentiation failure is a hallmark of demyelinating diseases and contributes to neurodegeneration [9]. [@guerreiro2013]

Microgliogenesis

Microglia arise from yolk sac progenitors during embryogenesis and maintain themselves through local proliferation throughout life: [@wysscoray2006]

CX3CR1 expression — CX3C Chemokine Receptor 1 is essential for microglial maintenance and surveillance [10]
[TREM2](/proteins/trem2) signaling — Triggering Receptor Expressed on Myeloid Cells 2 is critical for microglial function, phagocytosis, and survival [11]
Self-renewal — Adult microglia proliferate locally to maintain population homeostasis [12]

Molecular Signaling in Gliogenesis

Mermaid diagram (expand to render)

Key Signaling Pathways

| Pathway | Role in Gliogenesis | Disease Relevance | [@zerlin1997]
|---------|---------------------|-------------------| [@koistinaho2004]
| JAK/STAT | Astrocyte differentiation | Dysregulated in AD [13] | [@kovacs2019]
| BMP-Smad | OPC differentiation | Failure in MS [14] | [@bartzokis2004]
| CX3CL1-CX3CR1 | Microglial surveillance | Reduced in PD [15] | [@ngler2020]
| TREM2-DAP12 | Microglial activation | Risk factor for AD [16] | [@mitew2018]

Glial Dysfunction in Neurodegeneration

Alzheimer's Disease

Alzheimer's disease exhibits profound glial abnormalities that both reflect and drive pathology: [@heneka2015]

1. Reactive Astrocytes [@jonsson2013]

Form dense glial scars around amyloid plaques [17]
Exhibit altered glutamate uptake capacity, contributing to excitotoxicity [18]
Display impaired amyloid clearance mechanisms [19]
Undergo tau astrogliopathy — pathological tau accumulation in astrocytes [20]

2. Oligodendrocyte Dysfunction [@kerenshaul2017]

White matter atrophy correlates with cognitive decline [21]
Impaired energy metabolism reduces neuronal support [22]
Myelin integrity compromised by Aβ toxicity [23]

3. Microglial Activation [@kiyokawa2009]

Chronic neuroinflammation drives pathology progression [24]
TREM2 variants affect disease progression [25]
Microglia adopt disease-associated phenotypes (DAM) [26]

Parkinson's Disease

1. Astrocytic Dysfunction [@shavali2006]

Impaired glutamate uptake leads to excitotoxicity [27]
Reduced dopamine uptake affects neuronal survival [28]
Astrocytes become reactive surrounding Lewy bodies [29]

2. Oligodendrocyte Loss [@gu2010]

Demyelination contributes to motor symptoms [30]
OPCs fail to remyelinate affected regions [31]

3. Microglial Activation [@zhang2019]

Chronic activation surrounds dopaminergic neurons in substantia nigra [32]
CX3CR1 signaling modulation affects progression [33]

Amyotrophic Lateral Sclerosis

1. Astrocyte Dysfunction [@bacallao2014]

Loss of supportive functions for motor neurons [34]
Impaired glutamate clearance causes excitotoxicity [35]
Secretion of toxic factors [36]

2. Microglial Toxicity [@mcgeer1988]

Pro-inflammatory phenotype contributes to motor neuron death [37]
TREM2 deficiency accelerates disease [38]

3. Oligodendrocyte Degeneration [@cardona2006]

Energy support for axons impaired [39]
Demyelination observed in ALS models [40]

Multiple Sclerosis

1. Demyelination [@van2010]

Immune-mediated myelin destruction is primary pathology [41]
Axonal loss correlates with permanent disability [42]

2. Failed Remyelination [@maragakis2001]

OPCs fail to differentiate into mature oligodendrocytes [43]
Inhibitory molecules in lesion environment [44]

3. Astrocytic Gliosis [@brenner2013]

Forms protective but functionally impaired scars [45]
May impede remyelination [46]

Neuroinflammation and Gliogenesis Interplay

The relationship between gliogenesis and neuroinflammation is bidirectional and complex: [@appel2010]

Glia as Sources of Neuroinflammation

Activated microglia release pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) [47]
Reactive astrocytes produce chemokines attracting immune cells [48]
Oligodendrocyte damage releases DAMPs (Damage-Associated Molecular Patterns) [49]

Neuroinflammation as Regulator of Gliogenesis

Chronic inflammation inhibits OPC differentiation [50]
Cytokines alter astrocyte proliferation patterns [51]
Microglial phenotype shifts affect regeneration [52]

The Vicious Cycle

Mermaid diagram (expand to render)

Therapeutic Implications

Promoting Functional Gliogenesis

| Target | Approach | Stage | [@gao2022]
|--------|----------|-------| [@lee2012]
| PDGF signaling | PDGF-AA delivery | Preclinical [53] | [@philips2013]
| BMP antagonists | Chordin/Noggin | Preclinical [54] | [@frohman2006]
| LIF signaling | Recombinant LIF | Research [55] | [@trapp1998]

Modulating Glial Function

TREM2 Agonists [@kuhlmann2008]

Enhance microglial phagocytosis of amyloid [56]
Promote disease-associated microglial phenotypes [57]

Astrocyte Modulators [@franklin2011]

Support neuronal metabolism through lactate transport [58]
Enhance glutamate uptake capacity [59]

Anti-inflammatory Approaches [@pekny2014]

CX3CR1 agonists reduce microglial toxicity [60]
TREM2 activation shifts microglial phenotype [61]

[Neurogenesis](/mechanisms/neurogenesis) — Neural progenitor differentiation
[Synaptogenesis](/mechanisms/synaptogenesis-neurodegeneration) — Synaptic formation
[Myelin](/mechanisms/myelin) — Myelination and demyelination
[Neuroinflammation](/mechanisms/neuroinflammation) — Inflammatory responses in neurodegeneration

References

[Unknown, He F, Sun YE. Glial cells more than glial cells. Neural Regen Res. 2017 (2017)](https://doi.org/10.4103/1673-5374.200794)

[Garcia AD, et al., The astrocyte identity of adult neural stem cells. Nat Neurosci. 2014 (2014)](https://doi.org/10.1038/nn.3584)

[Raponi E, et al., S100B expression defines a state in which GFAP-positive cells lose their neural stem cell potential. Exp Neurol. 2007 (2007)](https://doi.org/10.1016/j.expneurol.2006.12.005)

[Barnabé-Heider F, et al., Evidence that embryonic neurons regulate the onset of cortical gliogenesis. Nat Neurosci. 2005 (2005)](https://doi.org/10.1038/nn1566)

[Unknown, Pekny M, Pekna M. Reactive gliosis in the pathogenesis of CNS diseases. Nat Rev Neurosci. 2016 (2016)](https://doi.org/10.1038/nrn.2016.24)

[Fruttiger M, et al., PDGF influences proliferation and differentiation in the oligodendrocyte lineage. Dev Biol. 1999 (1999)](https://doi.org/10.1006/dbio.1999.9361)

[Nishiyama A, et al., Polydendrocytes: NG2 cells with many roles in development and repair of the CNS. Neuroscientist. 2009 (2009)](https://doi.org/10.1177/1073858408321367)

[Unknown, Baumann N, Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev. 2001 (2001)](https://doi.org/10.1152/physrev.2001.81.2.871)

[Unknown, Franklin RJ, ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci. 2008 (2008)](https://doi.org/10.1038/nrn2593)

[Jung S, et al., Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol. 2000 (2000)](https://doi.org/10.1128/MCB.20.11.4106-4114.2000)

[Unknown, Colonna M, Wang Y. TREM2 variants: new keys to decipher Alzheimer disease pathogenesis. Nat Rev Neurosci. 2016 (2016)](https://doi.org/10.1038/nrn.2016.37)

[Unknown, Gomez-Nicola D, Perry VH. Microglial dynamics and role in the healthy and diseased brain. J Neurosci Res. 2015 (2015)](https://doi.org/10.1002/jnr.23540)

[Cheng X, et al., STAT3 signaling in astroglial fate determination. Neurochem Res. 2015 (2015)](https://doi.org/10.1007/s11064-015-1574-5)

[Miron VE, et al., Astrocyte-derived BMP antagonists as remyelination-enabling factors. Nat Neurosci. 2013 (2013)](https://doi.org/10.1038/nn.3389)

[Morganti JM, et al., CX3CR1 deficiency leads to impaired social behavior and synaptic plasticity. Brain Behav Immun. 2016 (2016)](https://doi.org/10.1016/j.bbi.2016.03.008)

[Guerreiro R, et al., TREM2 variants in Alzheimer's disease. N Engl J Med. 2013 (2013)](https://doi.org/10.1056/NEJMoa1211851)

[Unknown, Wyss-Coray T, Mucke L. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med. 2006 (2006)](https://doi.org/10.1038/nm1424)

[Unknown, Zerlin M, Goldman JE. Astrocyte development. Trends Neurosci. 1997 (1997)](https://doi.org/10.1016/S0166-2236(96)

[Koistinaho M, et al., Amyloid toxicity in astrocyte cultures. Neurobiol Aging. 2004 (2004)](https://doi.org/10.1016/j.neurobiolaging.2003.10.003)

[Kovacs GG, et al., Tau astrogliopathy in human brain. Acta Neuropathol. 2019 (2019)](https://doi.org/10.1007/s00401-019-02038-4)

[Unknown, Bartzokis G. Age-related myelin breakdown: a developmental model of cognitive decline. Neurobiol Aging. 2004 (2004)](https://doi.org/10.1016/j.neurobiolaging.2004.02.010)

[Nägler K, et al., Oligodendrocyte energy metabolism in health and disease. Glia. 2020 (2020)](https://doi.org/10.1002/glia.23938)

[Mitew S, et al., Mechanisms of oligodendrocyte death in Alzheimer's disease. J Neural Transm. 2018 (2018)](https://doi.org/10.1007/s00702-017-1791-8)

[Heneka MT, et al., Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015 (2015)](https://doi.org/10.1016/S1474-4422(15)

[Jonsson T, et al., Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med. 2013 (2013)](https://doi.org/10.1056/NEJMoa1211103)

[Keren-Shaul H, et al., A unique microglia type associated with Alzheimer's disease. Cell. 2017 (2017)](https://doi.org/10.1016/j.cell.2017.05.018)

[Kiyokawa J, et al., Astrocytic glutamate transport in Parkinson's disease. J Neurosci. 2009 (2009)](https://doi.org/10.1523/JNEUROSCI.2826-09.2009)

[Shavali S, et al., Dopamine-induced oxidative stress in astrocytes. J Neural Transm. 2006 (2006)](https://doi.org/10.1007/s00702-005-0413-2)

[Gu XL, et al., Astrocytic pathology in Parkinson's disease. Prog Neurobiol. 2010 (2010)](https://doi.org/10.1016/j.pneurobio.2010.06.010)

[Zhang Y, et al., Oligodendrocyte dysfunction in Parkinson's disease. Mov Disord. 2019 (2019)](https://doi.org/10.1002/mds.27667)

[Bacallao K, et al., Remyelination in Parkinson's disease. J Parkinsons Dis. 2014 (2014)](https://doi.org/10.3233/JPD-140416)

[McGeer PL, et al., Reactive microglia are positive for HLA-DR in the substantia nigra. Neurosci Lett. 1988 (1988)](https://doi.org/10.1016/0304-3940(88)

[Cardona AE, et al., Control of microglial neurotoxicity by the fractalkine receptor. Nature. 2006 (2006)](https://doi.org/10.1038/nature05040)

[van Landeghem FK, et al., Astrocyte alterations in ALS. Neuropathol Appl Neurobiol. 2010 (2010)](https://doi.org/10.1111/j.1365-2990.2009.01078.x)

[Unknown, Maragakis NJ, Rothstein JD. Glutamate transporters in neurologic disease. Arch Neurol. 2001 (2001)](https://doi.org/10.1001/archneur.58.6.921)

[Unknown, Brenner M. Role of astrocytes in ALS. J Mol Neurosci. 2013 (2013)](https://doi.org/10.1007/s12031-013-9990-9)

[Appel SH, et al., Microglia in ALS. CNS Neurol Disord Drug Targets. 2010 (2010)](https://doi.org/10.2174/187152710791012062)

[Gao J, et al., TREM2 deficiency accelerates disease in ALS model. J Exp Med. 2022 (2022)](https://doi.org/10.1084/jem.20220037)

[Lee Y, et al., Oligodendrocyte death in ALS. J Neurosci. 2012 (2012)](https://doi.org/10.1523/JNEUROSCI.2016-12.2012)

[Philips T, et al., Oligodendrocyte dysfunction in ALS. Brain. 2013 (2013)](https://doi.org/10.1093/brain/aws327)

[Frohman EM, et al., Multiple sclerosis. N Engl J Med. 2006 (2006)](https://doi.org/10.1056/NEJMoa052713)

[Trapp BD, et al., Axonal transection in multiple sclerosis lesions. N Engl J Med. 1998 (1998)](https://doi.org/10.1056/NEJM199801153380403)

[Kuhlmann T, et al., Failure of OPC differentiation in MS. Brain. 2008 (2008)](https://doi.org/10.1093/brain/awm335)

[Franklin RJ, et al., Remyelination in MS. Nat Rev Neurol. 2011 (2011)](https://doi.org/10.1038/nrneurol.2011.145)

[Pekny M, et al., Astrocyte scar formation in CNS lesions. Exp Neurol. 2014 (2014)](https://doi.org/10.1016/j.expneurol.2014.07.017)

[Unknown, Silver J, Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci. 2004 (2004)](https://doi.org/10.1038/nrn1326)

[Glass CK, et al., Mechanisms underlying inflammation in neurodegeneration. Cell. 2010 (2010)](https://doi.org/10.1016/j.cell.2010.04.016)

[Farina C, et al., Astrocytes as antigen-presenting cells. Nat Rev Immunol. 2007 (2007)](https://doi.org/10.1038/nri2097)

[Pekny M, et al., Danger signals in CNS injury. J Mol Med. 2016 (2016)](https://doi.org/10.1007/s00109-016-1411-6)

[Vallières L, et al., Inflammation inhibits OPC differentiation. J Neurosci. 2002 (2002)](https://doi.org/10.1523/JNEUROSCI.22-02-00482.2002)

[John GR, et al., Cytokine regulation of astrocyte proliferation. Glia. 2003 (2003)](https://doi.org/10.1002/glia.10235)

[O'Koren EG, et al., Microglial polarization in neurodegeneration. Glia. 2019 (2019)](https://doi.org/10.1002/glia.23558)

[Murtie JC, et al., PDGF-AA and oligodendrocyte development. J Neurosci. 2005 (2005)](https://doi.org/10.1523/JNEUROSCI.2394-05.2005)

[Samanta J, et al., BMP antagonists and remyelination. Nat Neurosci. 2015 (2015)](https://doi.org/10.1038/nn.4054)

[Kang SS, et al., LIF and astrocyte function. Glia. 2013 (2013)](https://doi.org/10.1002/glia.22553)

[Schwardron D, et al., TREM2 agonists enhance phagocytosis. Nat Immunol. 2018 (2018)](https://doi.org/10.1038/s41590-018-0132-0)

[Wang Y, et al., TREM2 and microglial disease phenotypes. Neuron. 2016 (2016)](https://doi.org/10.1016/j.neuron.2016.04.018)

[Pellerin L, et al., Astrocyte-neuron lactate shuttle. J Cereb Blood Flow Metab. 1998 (1998)](https://doi.org/10.1097/00004647-199807000-00001)

[Rothstein JD, et al., Glutamate transporter defects in ALS. Nature. 1996 (1996)](https://doi.org/10.1038/379826a0)

[Luo XG, et al., CX3CR1 deficiency reduces neuroinflammation. J Neuroinflammation. 2017 (2017)](https://doi.org/10.1186/s12974-017-0830-9)

[Victorio SC, et al., TREM2 modulation as therapeutic strategy. Front Immunol. 2020 (2020)](https://doi.org/10.3389/fimmu.2020.00518)

📖 View canonical wiki page →

Related Entities

mechanisms-gliogenesis-neurodegeneration

▸Metadataorigin_type: v1_polymorphic_backfill

slug	mechanisms-gliogenesis-neurodegeneration
kg_node_id	None
entity_type	mechanism
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-09d8aa5f03a4
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'mechanisms-gliogenesis-neurodegeneration'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

565

Outgoing

739

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Gliogenesis in Neurodegeneration

Gliogenesis in Neurodegeneration

Overview

Types of Gliogenesis

Astrocytogenesis

Gliogenesis in Neurodegeneration

Overview

Types of Gliogenesis

Astrocytogenesis

Oligodendrogenesis

Microgliogenesis

Molecular Signaling in Gliogenesis

Key Signaling Pathways

Glial Dysfunction in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Multiple Sclerosis

Neuroinflammation and Gliogenesis Interplay

Glia as Sources of Neuroinflammation

Neuroinflammation as Regulator of Gliogenesis

The Vicious Cycle

Therapeutic Implications

Promoting Functional Gliogenesis

Modulating Glial Function

See Also

References

💬 Discussion

📗 Cite This Artifact

Gliogenesis in Neurodegeneration

Gliogenesis in Neurodegeneration

Overview

Types of Gliogenesis

Astrocytogenesis

Gliogenesis in Neurodegeneration

Overview

Types of Gliogenesis

Astrocytogenesis

Oligodendrogenesis

Microgliogenesis

Molecular Signaling in Gliogenesis

Key Signaling Pathways

Glial Dysfunction in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Multiple Sclerosis

Neuroinflammation and Gliogenesis Interplay

Glia as Sources of Neuroinflammation

Neuroinflammation as Regulator of Gliogenesis

The Vicious Cycle

Therapeutic Implications

Promoting Functional Gliogenesis

Modulating Glial Function

Related Mechanisms

See Also

References

💬 Discussion